Details of Epigenetic Molecule(EM)
| General Information of EM (ID: EM12200) | |||||||
|---|---|---|---|---|---|---|---|
| Official Symbol |
MAP7D2
|
||||||
| Official Full Name |
MAP7 Domain Containing 2
|
||||||
| Synonym |
MAP7 Domain Containing 2;FLJ14503;MAP7 Domain-Containing Protein 2 Brain Specific Variant 1;MAP7 Domain-Containing Protein 2 Brain Specific Variant 2;MAP7 Domain Containing 2 Protein Varaint 1;MAP7 Domain Containing 2 Protein Varaint 2;MAP7 Domain Containing 2 Brain
|
||||||
| Molecule Type |
Protein coding
|
||||||
| Position On Chromosome |
chrX(Start:20006713 - End:20116907)
|
||||||
| Strand |
-
|
||||||
| Uniprot Entry | |||||||
| ENSG ID | |||||||
| Disease Relevance (Click to Show/Hide) | |||||||
| 8A01: Choreiform disorders | Huntington's disease (HD) [Choreiform disorders] | ||||||
| Detailed Information |
Disease Link
click to show the detail information of this Disease
|
||||||
| 8A20: Alzheimer disease | Alzheimer's disease [Alzheimer disease] | ||||||
| Detailed Information |
Disease Link
click to show the detail information of this Disease
|
||||||
| CB03: Idiopathic interstitial pneumonitis | Idiopathic pulmonary fibrosis (IPF) [Idiopathic interstitial pneumonitis] | ||||||
| Detailed Information |
Disease Link
click to show the detail information of this Disease
|
||||||
| SE30: Developmental delay disorder | CHARGE and Kabuki syndromes [Developmental delay disorder] | ||||||
| Detailed Information |
Disease Link
click to show the detail information of this Disease
|
||||||
| XH4XG8: Chronic myeloid leukaemia | Chronic Phase-Chronic Myeloid Leukemia [Chronic myeloid leukaemia] | ||||||
| Detailed Information |
Disease Link
click to show the detail information of this Disease
|
||||||
| ZERO(Not Found): Sex chromosome anomalies | X-chromosome inactivation (XCI) [Sex chromosome anomalies] | ||||||
| Detailed Information |
Disease Link
click to show the detail information of this Disease
|
||||||
| Metabolite(s) with this epigenetic modification | |||||||
|---|---|---|---|---|---|---|---|
| Metabolite Name: Valerate | |||||||
| Detailed Information |
Meta Info
click to show the detail information of this Metabolite
|
[1], [2] | |||||
| Description |
Valerate has been shown to hypermethylate MAP7D2 CpG site in breast cancer cells.
|
||||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Tang and Dr. Zhang.
